For people diagnosed with actual early stage breast cancer, there would be an end date to their drug therapy too. Maybe a year of Herceptin (trastuzumab), maybe five years of anti-estrogen, something, ...
In a retrospective analysis, patients with lung-only metastatic pancreatic ductal adenocarcinoma (PDAC) demonstrated a median overall survival of 28.7 months compared to 12.8 months for those with ...
Mort à 55 ans, Bruno Salomone a succombé à des métastases cervicales fulgurantes : comment ces lésions du cou ...
A team from the Spanish National Cancer Research Centre (CNIO) has discovered a novel way in which tumor cells alter the ...
Despite a lack of level 1 evidence, metastasis-directed therapy has been increasingly used for the treatment of oligometastatic prostate cancer based on findings from several randomized phase II ...
Researchers have discovered that cancer spread isn’t random—it follows a kind of biological “program.” By studying colon ...
A study at two US medical centers found that patients with brain metastases from gastrointestinal (GI) cancers had significantly worse overall survival and intracranial progression-free survival (PFS) ...
RemeGen Co., Ltd. a reçu le certificat d'enregistrement de médicament délivré par l'Administration nationale des produits ...
Nouvelle stratégie potentielle de traitement pour les tumeurs cérébrales et la maladie leptoméningée : HER3-DXd produit des résultats prometteurs dans le cadre de l’étude de phase II TUXEDO-3 à ...
Doctissimo on MSN
Cancer du sein : un premier espoir contre les redoutables métastases cérébrales et méningées
Quand le cancer du sein HER2+ atteint les méninges, les patientes manquent cruellement d’options. Une étude récente au MD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results